Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
Sales | 7,114,000 | 7,051,000 | 6,599,000 | 6,352,000 | 7,389,000 |
Cost of Goods | 2,090,000 | 1,565,000 | 1,442,000 | 1,401,000 | 1,396,000 |
Gross Profit | 5,024,000 | 5,486,000 | 5,157,000 | 4,951,000 | 5,993,000 |
Operating Expenses | 3,411,000 | 2,863,000 | 3,492,000 | 3,247,000 | 3,726,000 |
Operating Income | 1,612,000 | 2,623,000 | 1,665,000 | 1,705,000 | 2,267,000 |
Interest Expense | 252,000 | 232,000 | 230,000 | 230,000 | 226,000 |
Other Income | 293,000 | -73,000 | 153,000 | -175,000 | -10,000 |
Pre-tax Income | 1,653,000 | 2,318,000 | 1,588,000 | 1,300,000 | 2,031,000 |
Income Tax | 236,000 | 146,000 | 549,000 | 316,000 | 398,000 |
Net Income Continuous | 1,417,000 | 2,172,000 | 1,039,000 | 984,000 | 1,633,000 |
Minority Interests | -12,000 | -8,000 | -6,000 | -26,000 | -7,000 |
Net Income | $1,429,000 | $2,180,000 | $1,045,000 | $1,011,000 | $1,640,000 |
EPS Basic Total Ops | 1.14 | 1.75 | 0.84 | 0.81 | 1.30 |
EPS Basic Continuous Ops | 1.14 | 1.74 | 0.83 | 0.79 | 1.30 |
EPS Diluted Total Ops | 1.14 | 1.73 | 0.83 | 0.80 | 1.29 |
EPS Diluted Continuous Ops | 1.13 | 1.73 | 0.83 | 0.78 | 1.29 |
EPS Diluted Before Non-Recurring Items | 1.72 | 2.29 | 1.34 | 1.37 | 1.67 |
EBITDA(a) | $2,301,000 | $3,307,000 | $2,346,000 | $2,344,000 | $2,795,000 |